PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $670 | +5.3% | 21,843 | +37.7% | 0.01% | +60.0% |
| Q2 2023 | $636 | +46.9% | 15,864 | +49.7% | 0.01% | 0.0% |
| Q1 2023 | $433 | +324.5% | 10,600 | +301.7% | 0.01% | +400.0% |
| Q4 2022 | $102 | -100.0% | 2,639 | -71.2% | 0.00% | -83.3% |
| Q3 2022 | $487,000 | -48.8% | 9,148 | -44.0% | 0.01% | -40.0% |
| Q2 2022 | $952,000 | +3.6% | 16,331 | +35.7% | 0.01% | +42.9% |
| Q1 2022 | $919,000 | -44.4% | 12,037 | -56.2% | 0.01% | -22.2% |
| Q4 2021 | $1,652,000 | +227.1% | 27,459 | +204.6% | 0.01% | +350.0% |
| Q3 2021 | $505,000 | +36.9% | 9,014 | +48.4% | 0.00% | 0.0% |
| Q2 2021 | $369,000 | -70.7% | 6,076 | -66.2% | 0.00% | -71.4% |
| Q1 2021 | $1,259,000 | -67.5% | 17,961 | -72.2% | 0.01% | -66.7% |
| Q4 2020 | $3,872,000 | +90.7% | 64,702 | +91.6% | 0.02% | +61.5% |
| Q3 2020 | $2,030,000 | +1271.6% | 33,767 | +1098.7% | 0.01% | +1200.0% |
| Q2 2020 | $148,000 | -49.7% | 2,817 | -67.9% | 0.00% | -66.7% |
| Q1 2020 | $294,000 | +25.6% | 8,771 | +70.0% | 0.00% | +50.0% |
| Q4 2019 | $234,000 | -16.1% | 5,159 | -29.6% | 0.00% | 0.0% |
| Q3 2019 | $279,000 | -92.4% | 7,323 | -91.4% | 0.00% | -92.0% |
| Q2 2019 | $3,685,000 | +3076.7% | 84,743 | +2683.9% | 0.02% | +2400.0% |
| Q1 2019 | $116,000 | +7.4% | 3,044 | +21.6% | 0.00% | 0.0% |
| Q4 2018 | $108,000 | -72.7% | 2,504 | -76.3% | 0.00% | -66.7% |
| Q3 2017 | $396,000 | +29.8% | 10,559 | +65.1% | 0.00% | 0.0% |
| Q2 2017 | $305,000 | +146.0% | 6,395 | +135.6% | 0.00% | +200.0% |
| Q1 2017 | $124,000 | -76.3% | 2,714 | -83.2% | 0.00% | -75.0% |
| Q4 2016 | $523,000 | +105.9% | 16,185 | +117.8% | 0.00% | +33.3% |
| Q3 2016 | $254,000 | -11.5% | 7,431 | -12.6% | 0.00% | +50.0% |
| Q2 2016 | $287,000 | +49.5% | 8,499 | +135.0% | 0.00% | +100.0% |
| Q1 2016 | $192,000 | +73.0% | 3,616 | +149.9% | 0.00% | 0.0% |
| Q4 2015 | $111,000 | -72.6% | 1,447 | -85.3% | 0.00% | -50.0% |
| Q3 2015 | $405,000 | +170.0% | 9,845 | +362.9% | 0.00% | +100.0% |
| Q2 2015 | $150,000 | -10.2% | 2,127 | +12.9% | 0.00% | 0.0% |
| Q1 2015 | $167,000 | -78.3% | 1,884 | -78.3% | 0.00% | -75.0% |
| Q4 2014 | $770,000 | +84.7% | 8,683 | +101.8% | 0.00% | +100.0% |
| Q3 2014 | $417,000 | +169.0% | 4,302 | +155.2% | 0.00% | +100.0% |
| Q2 2014 | $155,000 | -39.2% | 1,686 | -68.2% | 0.00% | 0.0% |
| Q3 2013 | $255,000 | – | 5,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |